Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jan;21(1):66-68.
doi: 10.1016/j.clml.2020.06.012. Epub 2020 Jun 25.

Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma

Zachary Wright  1 , Adrian Bersabe  2 , Rina Eden  3 , Jessica Bradley  3 , Andrew Cap  4
Affiliations
Case Reports

Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma

Zachary Wright et al. Clin Lymphoma Myeloma Leuk. 2021 Jan.
No abstract available

Keywords: CCP; COVID; Hypogammaglobulinemia; Lymphopenia; lymphoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Portable Chest X-ray of Patient Taken 2 days Prior to CCP With Improvement Noted in Follow-up Chest X-ray 6 days after CCP Transfusion Abbreviations: CCP = COVID-19 convalescent plasma (CCP); COVID-19 = coronavirus disease 2019.
Figure 2
Figure 2
Fever and C-reactive Protein Trends Through Patient’s Hospitalization Abbreviations: CCP = COVID-19 convalescent plasma (CCP); COVID-19 = coronavirus disease 2019; CRP = C-reactive protein; Tmax = maximum temperature.
See this image and copyright information in PMC

References

    1. Martino R., Ramila E., Rabella N. Respiratory virus infections in adults with hematologic malignancies: a prospective study. Clin Infect Dis. 2003;36:1–8. - PMC - PubMed
    1. Hakki M., Rattray R.M., Press R.D. The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients. J Clin Virol. 2015;68:1–5. - PMC - PubMed
    1. Dai M., Lui D., Liu M. Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov. 2020;10:783–791. - PMC - PubMed
    1. United States Food and Drug Administration COVID-19-related guidance documents for industry, FDA staff, and other stakeholders. https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/covid... Available at: Accessed: July 10, 2020.
    1. Ye M., Fu D., Ren Y. Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. J Med Vir 2020 Apr 15. https://doi.org/10.1002/jmv.25882 [Epub ahead of print] - DOI - PMC - PubMed

Publication types